Opioid use in the management of diabetic peripheral neuropathy (DPN) in a large commercially insured population.

ABSTRACT:

Objective

To examine the proportion of diabetic peripheral neuropathy (DPN) patients receiving pharmacologic DPN treatments and specifically to identify the rates and factors associated with opioid use and first-line opioid use.

Methods

A 10% sample of IMS-LifeLink claims data from 1998 through 2008 was used. The study population consisted of diabetic patients who met DPN criteria using a validated DPN algorithm. Multivariable logistic regression controlling for demographics, comorbidities, and other clinical characteristics was used to identify factors associated with any DPN pharmacologic treatment, any opioid use, and first-line opioid treatment. Sensitivity analyses were conducted to explore variations in exclusion criteria as well as opioid use definitions.

Results</

SUBMITTER: Patil PR 

PROVIDER: S-EPMC4391274 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature